PERRIGO COMPANY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.02 USD | -0.29% |
|
-6.17% | -3.60% |
| 07/05 | Perrigo's Q1 Adjusted Earnings, Net Sales Drop | MT |
| 07/05 | Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024 |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 4.62B 386B | Sales 2025 * | 4.83B 403B | Capitalization | 4.23B 353B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M -6.18B | Net income 2025 * | 106M 8.85B | EV / Sales 2024 * | 1.61 x |
| Net Debt 2024 * | 3.21B 268B | Net Debt 2025 * | 3.01B 251B | EV / Sales 2025 * | 1.5 x |
| P/E ratio 2024 * |
-21.4
x | P/E ratio 2025 * |
194
x | Employees | 9,140 |
| Yield 2024 * |
3.55% | Yield 2025 * |
3.78% | Free-Float | 99.12% |
More Fundamentals
* Assessed data
More news
Latest transcript on Perrigo Company plc
More recommendations
More press releases
More news
| 1 day | -0.29% | ||
| 1 week | -6.17% | ||
| Current month | -5.02% | ||
| 1 month | -3.72% | ||
| 3 months | -2.70% | ||
| 6 months | +10.43% | ||
| Current year | -3.60% |
1 week
30.08
33.46
1 month
29.7933.46
Current year
25.7734.60
1 year
25.7740.28
3 years
25.7750.90
5 years
25.7763.86
10 years
25.77215.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 30/23/30 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 16/22/16 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 15/20/15 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 06/17/06 |
Bradley Alford
BRD | Director/Board Member | 67 | 06/17/06 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 18.63% | 13 M€ | -.--% | ||
| 15.31% | 0 M€ | +11.39% | - | |
| 0.66% | 8 M€ | +5.48% | - | |
| 0.46% | 0 M€ | +8.89% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/24/09 | 31.02 | -0.29% | 1,093,712 |
| 08/24/08 | 31.11 | +3.18% | 1,711,065 |
| 07/24/07 | 30.15 | -9.81% | 3,898,066 |
| 06/24/06 | 33.43 | +1.95% | 1,730,332 |
| 03/24/03 | 32.79 | -0.82% | 981,835 |
Delayed Quote Nyse, May 10, 2024 at 01:30 am IST
More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Sector
Pharmaceuticals
Calendar
07/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
31.02
USD
Average target price
39.5
USD
Spread / Average Target
+27.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.60% | 4.23B | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +17.04% | 239B | |
| +8.02% | 204B | |
| -7.53% | 198B | |
| +8.62% | 168B |
- Stock Market
- Equities
- PRGO Stock